PJP vs. EKG

Last updated Jun 24, 2026

PJP (Invesco Dynamic Pharmaceuticals ETF) and EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) are both Health & Biotech Equities funds - PJP tracks the Dynamic Pharmaceuticals Intellidex Index while EKG tracks the NASDAQ Lux Health Tech Index. Both are passively managed. Over the past 3 years, PJP returned 15.79%/yr vs -0.25%/yr for EKG. A 0.57 correlation means they provide meaningful diversification when combined. PJP charges 0.58%/yr vs 0.65%/yr for EKG.

Performance

PJP vs. EKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PJP achieves a 9.74% return, which is significantly higher than EKG's -7.35% return.

PJP

• 1D: 1.74%
• 1M: 4.87%
• YTD: 9.74%
• 6M: 7.29%
• 1Y: 44.65%
• 3Y*: 15.79%
• 5Y*: 8.32%
• 10Y*: 7.44%

EKG

• 1D: 1.44%
• 1M: 5.58%
• YTD: -7.35%
• 6M: -8.68%
• 1Y: 2.67%
• 3Y*: -0.25%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. EKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
PJP Invesco Dynamic Pharmaceuticals ETF	9.74%	27.98%	9.63%	-2.18%	-0.64%
EKG First Trust Nasdaq Lux Digital Health Solutions ETF	-7.35%	11.89%	6.53%	-0.11%	-20.15%

Correlation

The correlation between PJP and EKG is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.48
Correlation (3Y) Calculated over the trailing 3-year period	0.50
Correlation (All Time) Calculated using the full available price history since Mar 23, 2022	0.57

The correlation between PJP and EKG has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.

PJP vs. EKG - Sectors Allocation Comparison

Sectors	PJP	EKG
Healthcare	100.0%	94.9%
Financial Services	0.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	2.6%
Utilities	-	-

Return for Risk

PJP vs. EKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP

PJP Risk / Return Rank: 85
PJP Sharpe Ratio Rank: 87
PJP Sortino Ratio Rank: 88
PJP Omega Ratio Rank: 81
PJP Calmar Ratio Rank: 87
PJP Martin Ratio Rank: 81

EKG

EKG Risk / Return Rank: 10
EKG Sharpe Ratio Rank: 10
EKG Sortino Ratio Rank: 10
EKG Omega Ratio Rank: 10
EKG Calmar Ratio Rank: 10
EKG Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. EKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PJP	EKG	Difference
Sharpe ratio: Return per unit of total volatility	2.71	0.12	+2.59
Sortino ratio: Return per unit of downside risk	3.79	0.33	+3.46
Omega ratio: Gain probability vs. loss probability	1.45	1.04	+0.41
Calmar ratio: Return relative to maximum drawdown	4.75	0.12	+4.63
Martin ratio: Return relative to average drawdown	15.06	0.26	+14.80

PJP vs. EKG - Sharpe Ratio Comparison

The current PJP Sharpe Ratio is 2.71, which is higher than the EKG Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of PJP and EKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PJP vs. EKG - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum EKG drawdown of -43.82%. Use the drawdown chart below to compare losses from any high point for PJP and EKG.

Drawdown Indicators

	PJP	EKG	Difference
Max Drawdown Largest peak-to-trough decline	-37.06%	-43.82%	+6.76%
Max Drawdown (1Y) Largest decline over 1 year	-9.44%	-22.09%	+12.65%
Max Drawdown (3Y) Largest decline over 3 years	-16.27%	-34.49%	+18.22%
Max Drawdown (5Y) Largest decline over 5 years	-17.51%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-33.95%	—	—
Current Drawdown Current decline from peak	0.00%	-18.36%	+18.36%
Average Drawdown Average peak-to-trough decline	-8.83%	-22.59%	+13.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.97%	10.17%	-7.20%

Volatility

PJP vs. EKG - Volatility Comparison

The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.39%, while First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has a volatility of 8.01%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than EKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PJP	EKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.39%	8.01%	-2.62%
Volatility (6M) Calculated over the trailing 6-month period	12.46%	17.55%	-5.09%
Volatility (1Y) Calculated over the trailing 1-year period	16.58%	22.29%	-5.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.20%	27.08%	-10.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.37%	27.08%	-8.71%

PJP vs. EKG - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is lower than EKG's 0.65% expense ratio.

Dividends

PJP vs. EKG - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.93%, while EKG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EKG First Trust Nasdaq Lux Digital Health Solutions ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PJP Invesco Dynamic Pharmaceuticals ETF	0.93%	0.98%	0.97%	1.01%	0.95%	0.81%	0.75%	0.77%	1.12%	0.65%	0.91%	5.49%

Frequently Asked Questions

Can I hold both PJP and EKG in my portfolio?

PJP and EKG have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PJP or EKG?

EKG has higher volatility (8.01%) compared to PJP (5.39%). In terms of maximum drawdown, PJP dropped -37.06% vs EKG's -43.82%.

Which ETF is better, PJP or EKG?

On 3-year performance, PJP leads with 15.79% vs -0.25% for EKG. On fees, PJP is cheaper at 0.58% per year. On volatility, PJP has been the lower-risk option at 5.39%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, PJP or EKG?

Over the 3-year period, PJP has performed better with a 15.79% return vs -0.25%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, PJP or EKG?

PJP is cheaper with a 0.58% expense ratio, compared with 0.65% for EKG.

Which ETF pays a higher dividend yield, PJP or EKG?

PJP has the higher dividend yield at 0.93%, compared with 0.00% for EKG.

What is the main difference between PJP and EKG?

PJP tracks Dynamic Pharmaceuticals Intellidex Index, while EKG tracks NASDAQ Lux Health Tech Index. They also come from different issuers: Invesco and First Trust. Their fees differ too: 0.58% for PJP and 0.65% for EKG.

Which has better risk-adjusted returns?

PJP currently has the higher Sharpe Ratio (2.71 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.